{"ticker": {"uuid": "fc5cd577-e360-436d-98ef-a963160c287a", "symbol": "IP", "name": "Interpump Group S.p.A.", "exchange": "MIL", "country": "IT", "sector": "Industrials", "industry": "Specialty Industrial Machinery"}, "articles": [{"title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "summary": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T14:30:00+00:00", "published_display": "11 Aug 2026 14:30", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.214, "duplicate_count": 1, "topics": ["Biotech", "Competition", "Earnings", "Fda Approval", "Oncology", "Quarterly Results"]}, {"title": "CEZ Raises 2026 Outlook as Nuclear Output and Power Prices Improve", "summary": "Czech utility CEZ Group raised its full-year 2026 earnings forecast after reporting a 20% decline in first-half EBITDA as lower realized electricity prices weighed on its generation business. The company now expects full-year EBITDA of CZK 109 billion to CZK 114 billion, while adjusted net profit is forecast at CZK 31 billion to CZK 35 billion. CEZ attributed the upgrade to improved results from its electricity distribution business, higher-than-expected output from nuclear plants and an increase in electricity selling prices linked to higher energy commodity prices during the Persian Gulf cri", "url": "https://finance.yahoo.com/energy/articles/cez-raises-2026-outlook-nuclear-103954785.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T10:39:54+00:00", "published_display": "11 Aug 2026 10:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.208, "duplicate_count": 1, "topics": ["Earnings", "Electricity", "Energy", "Nuclear", "Utilities"]}], "by_tier": {"direct": [{"title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "summary": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T14:30:00+00:00", "published_display": "11 Aug 2026 14:30", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.214, "duplicate_count": 1, "topics": ["Biotech", "Competition", "Earnings", "Fda Approval", "Oncology", "Quarterly Results"]}, {"title": "CEZ Raises 2026 Outlook as Nuclear Output and Power Prices Improve", "summary": "Czech utility CEZ Group raised its full-year 2026 earnings forecast after reporting a 20% decline in first-half EBITDA as lower realized electricity prices weighed on its generation business. The company now expects full-year EBITDA of CZK 109 billion to CZK 114 billion, while adjusted net profit is forecast at CZK 31 billion to CZK 35 billion. CEZ attributed the upgrade to improved results from its electricity distribution business, higher-than-expected output from nuclear plants and an increase in electricity selling prices linked to higher energy commodity prices during the Persian Gulf cri", "url": "https://finance.yahoo.com/energy/articles/cez-raises-2026-outlook-nuclear-103954785.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T10:39:54+00:00", "published_display": "11 Aug 2026 10:39", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.208, "duplicate_count": 1, "topics": ["Earnings", "Electricity", "Energy", "Nuclear", "Utilities"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 2}, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 305, "call_budget": 500, "budget_used_pct": 61.0, "requests_made": 61, "last_success_at": "2026-08-13T11:00:32.128838+00:00", "newest_seen_at": "2026-08-13T10:15:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3239, "unmapped_mentions": 1964}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 0, "score": 55, "raw_score": 61, "total": 2, "evidence_count": 2, "effective_articles": 2.0, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 21, "confidence": 51, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-11T14:30:00+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 1, "negative_events": 1, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 2}, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 305, "call_budget": 500, "budget_used_pct": 61.0, "requests_made": 61, "last_success_at": "2026-08-13T11:00:32.128838+00:00", "newest_seen_at": "2026-08-13T10:15:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3239, "unmapped_mentions": 1964}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 38.18, "latest_week": "2026-08-07", "one_week_move": 9.2, "four_week_move": 16.7, "twelve_week_move": 14.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.530484, "market_dynamics_buy_signal": false, "relative_strength": -17.124316, "fair_value_gap": -3.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.9412, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.2% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 54, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "51/100", "tone": "neutral", "text": "2.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "21/100", "tone": "neutral", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+9.2% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?"}], "updated_at": "2026-08-13T11:04:19.040652+00:00", "detail_intelligence": {"headline": "Price moving ahead of tone", "summary": "Balanced news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 55, "display": "55", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 51, "display": "51", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 79, "display": "79", "tone": "positive", "note": "21/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 25, "note": "2.0 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 72, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 79, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 72, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 2, "score": 61, "tone": "positive", "x": 866.4, "y": 115.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "866.4,115.0", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 61, "prior_score": null, "delta": null, "recent_count": 2, "prior_count": 0, "volume_delta": 2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 2, "share": 100}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 61, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 2, "share": 100, "score": 61, "tone": "positive"}], "topics": [{"label": "Earnings", "count": 2, "share": 100}, {"label": "Utilities", "count": 1, "share": 50}, {"label": "Quarterly Results", "count": 1, "share": 50}, {"label": "Oncology", "count": 1, "share": 50}, {"label": "Nuclear", "count": 1, "share": 50}, {"label": "Fda Approval", "count": 1, "share": 50}, {"label": "Energy", "count": 1, "share": 50}, {"label": "Electricity", "count": 1, "share": 50}, {"label": "Competition", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to IP."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 79/100, indicating a comparatively coherent tape."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Price disagreement", "text": "Price is moving more forcefully than the current news tone suggests."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "summary": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T14:30:00+00:00", "published_display": "11 Aug 2026 14:30", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.216, "duplicate_count": 1, "topics": ["Biotech", "Competition", "Earnings", "Fda Approval", "Oncology", "Quarterly Results"]}, "article_count": 2, "updated_at": "2026-08-13T09:33:58.285348+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 55.8, "label": "13 Feb 2026", "close": 41.07, "index": 100.0}, {"x": 78.4, "y": 74.7, "label": "20 Feb 2026", "close": 39.74, "index": 96.8}, {"x": 114.7, "y": 89.7, "label": "27 Feb 2026", "close": 38.69, "index": 94.2}, {"x": 151.1, "y": 137.6, "label": "06 Mar 2026", "close": 35.33, "index": 86.0}, {"x": 187.4, "y": 179.9, "label": "13 Mar 2026", "close": 32.36, "index": 78.8}, {"x": 223.8, "y": 204.2, "label": "20 Mar 2026", "close": 30.66, "index": 74.7}, {"x": 260.1, "y": 181.1, "label": "27 Mar 2026", "close": 32.28, "index": 78.6}, {"x": 296.5, "y": 154.0, "label": "03 Apr 2026", "close": 34.18, "index": 83.2}, {"x": 332.9, "y": 110.8, "label": "10 Apr 2026", "close": 37.21, "index": 90.6}, {"x": 369.2, "y": 95.6, "label": "17 Apr 2026", "close": 38.28, "index": 93.2}, {"x": 405.6, "y": 131.4, "label": "24 Apr 2026", "close": 35.76, "index": 87.1}, {"x": 441.9, "y": 136.5, "label": "01 May 2026", "close": 35.41, "index": 86.2}, {"x": 478.3, "y": 131.1, "label": "08 May 2026", "close": 35.78, "index": 87.1}, {"x": 514.6, "y": 165.5, "label": "15 May 2026", "close": 33.37, "index": 81.3}, {"x": 551.0, "y": 144.3, "label": "22 May 2026", "close": 34.86, "index": 84.9}, {"x": 587.4, "y": 129.8, "label": "29 May 2026", "close": 35.88, "index": 87.4}, {"x": 623.7, "y": 151.7, "label": "05 Jun 2026", "close": 34.34, "index": 83.6}, {"x": 660.1, "y": 142.3, "label": "12 Jun 2026", "close": 35.0, "index": 85.2}, {"x": 696.4, "y": 135.8, "label": "19 Jun 2026", "close": 35.46, "index": 86.3}, {"x": 732.8, "y": 154.9, "label": "26 Jun 2026", "close": 34.12, "index": 83.1}, {"x": 769.1, "y": 144.9, "label": "03 Jul 2026", "close": 34.82, "index": 84.8}, {"x": 805.5, "y": 174.8, "label": "10 Jul 2026", "close": 32.72, "index": 79.7}, {"x": 841.9, "y": 129.5, "label": "17 Jul 2026", "close": 35.9, "index": 87.4}, {"x": 878.2, "y": 152.0, "label": "24 Jul 2026", "close": 34.32, "index": 83.6}, {"x": 914.6, "y": 142.9, "label": "31 Jul 2026", "close": 34.96, "index": 85.1}, {"x": 950.9, "y": 97.0, "label": "07 Aug 2026", "close": 38.18, "index": 93.0}], "sentiment_points": [{"x": 705.1, "y": 130.0, "label": "20 Jun 2026", "score": 50}, {"x": 705.5, "y": 130.0, "label": "20 Jun 2026", "score": 50}, {"x": 710.8, "y": 130.0, "label": "21 Jun 2026", "score": 50}, {"x": 716.9, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 717.3, "y": 130.0, "label": "23 Jun 2026", "score": 50}, {"x": 727.2, "y": 130.0, "label": "24 Jun 2026", "score": 50}, {"x": 742.4, "y": 130.0, "label": "27 Jun 2026", "score": 50}, {"x": 744.1, "y": 130.0, "label": "28 Jun 2026", "score": 50}, {"x": 744.5, "y": 130.0, "label": "28 Jun 2026", "score": 50}, {"x": 744.8, "y": 130.0, "label": "28 Jun 2026", "score": 50}, {"x": 751.0, "y": 130.0, "label": "29 Jun 2026", "score": 50}, {"x": 751.8, "y": 130.0, "label": "29 Jun 2026", "score": 50}, {"x": 767.5, "y": 130.0, "label": "02 Jul 2026", "score": 50}, {"x": 770.8, "y": 130.0, "label": "03 Jul 2026", "score": 50}, {"x": 833.1, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 833.3, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 845.7, "y": 130.0, "label": "17 Jul 2026", "score": 50}, {"x": 852.1, "y": 130.0, "label": "18 Jul 2026", "score": 50}, {"x": 853.9, "y": 130.0, "label": "19 Jul 2026", "score": 50}, {"x": 859.6, "y": 130.0, "label": "20 Jul 2026", "score": 50}, {"x": 867.1, "y": 130.0, "label": "21 Jul 2026", "score": 50}, {"x": 877.6, "y": 130.0, "label": "23 Jul 2026", "score": 50}, {"x": 915.0, "y": 130.0, "label": "31 Jul 2026", "score": 50}, {"x": 927.8, "y": 130.0, "label": "02 Aug 2026", "score": 50}, {"x": 954.0, "y": 130.0, "label": "07 Aug 2026", "score": 50}, {"x": 958.0, "y": 130.0, "label": "08 Aug 2026", "score": 50}], "price_path": "42.0,55.8 78.4,74.7 114.7,89.7 151.1,137.6 187.4,179.9 223.8,204.2 260.1,181.1 296.5,154.0 332.9,110.8 369.2,95.6 405.6,131.4 441.9,136.5 478.3,131.1 514.6,165.5 551.0,144.3 587.4,129.8 623.7,151.7 660.1,142.3 696.4,135.8 732.8,154.9 769.1,144.9 805.5,174.8 841.9,129.5 878.2,152.0 914.6,142.9 950.9,97.0", "sentiment_path": "705.1,130.0 705.5,130.0 710.8,130.0 716.9,130.0 717.3,130.0 727.2,130.0 742.4,130.0 744.1,130.0 744.5,130.0 744.8,130.0 751.0,130.0 751.8,130.0 767.5,130.0 770.8,130.0 833.1,130.0 833.3,130.0 845.7,130.0 852.1,130.0 853.9,130.0 859.6,130.0 867.1,130.0 877.6,130.0 915.0,130.0 927.8,130.0 954.0,130.0 958.0,130.0", "price_change": -7.0, "sentiment_change": 0, "latest_close": 38.18, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}